These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36906819)

  • 1. Allosteric inhibition of TEM-1 β lactamase: Microsecond molecular dynamics simulations provide mechanistic insights.
    Hellemann E; Nallathambi A; Durrant JD
    Protein Sci; 2023 Apr; 32(4):e4622. PubMed ID: 36906819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics.
    Galdadas I; Qu S; Oliveira ASF; Olehnovics E; Mack AR; Mojica MF; Agarwal PK; Tooke CL; Gervasio FL; Spencer J; Bonomo RA; Mulholland AJ; Haider S
    Elife; 2021 Mar; 10():. PubMed ID: 33755013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
    Gehlot P; P H
    Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of TEM-1 by avibactam (NXL-104): insights from quantum mechanics/molecular mechanics metadynamics simulations.
    Sgrignani J; Grazioso G; De Amici M; Colombo G
    Biochemistry; 2014 Aug; 53(31):5174-85. PubMed ID: 25050826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of TEM-1 beta-lactamase to beta-lactam antibiotics by frontal affinity chromatography.
    Chen X; Li Y; Zhang Y; Yang J; Bian L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():75-83. PubMed ID: 28334649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution of bacterial beta-lactam resistance.
    Knox JR; Moews PC; Frere JM
    Chem Biol; 1996 Nov; 3(11):937-47. PubMed ID: 8939710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the acylation mechanisms of active-site serine penicillin-recognizing proteins: a molecular dynamics simulation study.
    Oliva M; Dideberg O; Field MJ
    Proteins; 2003 Oct; 53(1):88-100. PubMed ID: 12945052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 10. β-lactam resistance: The role of low molecular weight penicillin binding proteins, β-lactamases and ld-transpeptidases in bacteria associated with respiratory tract infections.
    Ealand CS; Machowski EE; Kana BD
    IUBMB Life; 2018 Sep; 70(9):855-868. PubMed ID: 29717815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a hidden site on class A beta-lactamases.
    Avci FG; Altinisik FE; Karacan I; Senturk Karagoz D; Ersahin S; Eren A; Sayar NA; Vardar Ulu D; Ozkirimli E; Sariyar Akbulut B
    J Mol Graph Model; 2018 Sep; 84():125-133. PubMed ID: 29960255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
    Kumar KM; Anbarasu A; Ramaiah S
    Mol Biosyst; 2014 Apr; 10(4):891-900. PubMed ID: 24503740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics of class A β-lactamases-effects of substrate binding.
    Fisette O; Gagné S; Lagüe P
    Biophys J; 2012 Oct; 103(8):1790-801. PubMed ID: 23083723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication between the active site and the allosteric site in class A beta-lactamases.
    Meneksedag D; Dogan A; Kanlikilicer P; Ozkirimli E
    Comput Biol Chem; 2013 Apr; 43():1-10. PubMed ID: 23314151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation the role of mutations M182T and Q39K in structure of beta-lactamase TEM-72 by molecular dynamics method].
    Shcherbinin DS; Rubtsova MY; Grigorenko VG; Uporov IV; Veselovsky AV; Egorov AM
    Biomed Khim; 2016 Jul; 62(5):527-534. PubMed ID: 27797327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of the TEM-1 beta-lactamase complexed with cephalothin.
    Díaz N; Suárez D; Merz KM; Sordo TL
    J Med Chem; 2005 Feb; 48(3):780-91. PubMed ID: 15689162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.
    Wang YT; Lu CY; Hour TC; Cheng TL
    Curr Comput Aided Drug Des; 2014; 10(3):197-204. PubMed ID: 25479381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study.
    Baig MH; Sudhakar DR; Kalaiarasan P; Subbarao N; Wadhawa G; Lohani M; Khan MK; Khan AU
    PLoS One; 2014; 9(12):e112456. PubMed ID: 25479359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing intermolecular interactions and binding stability of antimicrobial peptides with beta-lactamase of
    Chakkyarath V; Natarajan J
    J Biomol Struct Dyn; 2022; 40(24):13641-13657. PubMed ID: 34676806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.